Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Interventional × evolocumab × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 340 Cyclophosphamide 332 Carboplatin 267 Gemcitabine 241 Paclitaxel 238 Nivolumab 225 Cisplatin 208 Radiotherapy 187 Bevacizumab 174 fludarabine 162 Dexamethasone 161 Docetaxel 160 Rituximab 153 Capecitabine 142 Lenalidomide 129 Oxaliplatin 128 Fluorouracil 122 Temozolomide 117 Cytarabine 113 Irinotecan 109 Cetuximab 109 Etoposide 108 venetoclax 104 fludarabine phosphate 104 Doxorubicin 96 130-nm albumin-bound paclitaxel 95 Injections 94 Azacitidine 93 Ipilimumab 92 Pemetrexed 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03337698 2025-12-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡